Hosted on MSN41m
FDA Approves Susvimo for Diabetic Macular EdemaThe U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback